For clinicians seeking quick updates on evidence, resources like PubMed can help locate peerreviewed studies, and databases such as ClinicalTrials.gov list active investigations
It has recently been reported that human GLP-1 analogues were more effective in reducing the occurrence of major adverse cardiovascular events, myocardial infarctions, and hospitalizations due to cardiovascular causes when compared to exendin-based GLP-1RAs [71]
This includes planned exercise (like workouts sometimes called Exercise Activity Thermogenesis) and everyday activities such as walking, fidgeting, or doing chores (Non-Exercise Activity Thermogenesis)
Obviously many things needs to be factored in when making the decision to carve off large group and over to Medicare if eligible (IRMAA, family health coverage implications, other medications being covered by traditional part d and the $2100 cap, doctor access, etc.) but this could be a way to keep access to these medications at a $50 charge
Compounded GLP-1s are produced in FDA-regulated facilities, but the medications themselves are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before marketing
